We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
+0.48%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$94M
AUM Growth
-$42.5M
Cap. Flow
-$40.4M
Cap. Flow %
-42.99%
Top 10 Hldgs %
84.92%
Holding
30
New
1
Increased
3
Reduced
6
Closed
8

Top Buys

Rank Stock Value
1
PETQ
PetIQ, Inc. Class A Common Stock
PETQ
+$3.43M
2
AMZN icon
Amazon
AMZN
+$1.47M
3
BBBY
Bed Bath & Beyond
BBBY
+$481K
4
ATRS
Antares Pharma, Inc.
ATRS
+$449K

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$6.06M
2
META icon
Meta Platforms (Facebook)
META
+$3.09M
3
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$2.78M
4
CMG icon
Chipotle Mexican Grill
CMG
+$2.77M
5
ISRG icon
Intuitive Surgical
ISRG
+$2.09M

Sector Composition

Rank Sector Weight
1 Healthcare 59.03%
2 Consumer Discretionary 28.36%
3 Communication Services 7.04%
4 Technology 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$25.4M 27.04%
475,755
-50,000
-10% -$2.78M
AMZN icon
2
Amazon
AMZN
$2.49T
$23M 24.42%
392,540
+26,800
+7% +$1.47M
META icon
3
Meta Platforms (Facebook)
META
$1.51T
$6.62M 7.04%
37,500
-17,500
-32% -$3.09M
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.95M 4.21%
270,775
– –
ATRS
5
DELISTED
Antares Pharma, Inc.
ATRS
$3.74M 3.98%
1,878,323
+206,367
+12% +$449K
PETQ
6
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$3.69M 3.92%
168,855
+148,855
+744% +$3.43M
AVDL
7
DELISTED
Avadel Pharmaceuticals
AVDL
$3.64M 3.88%
444,439
– –
MSFT icon
8
Microsoft
MSFT
$2.96T
$3.55M 3.78%
41,500
-11,500
-22% -$943K
BSTC
9
DELISTED
BioSpecifics Technologies Corp.
BSTC
$3.19M 3.4%
73,649
– –
BABA icon
10
Alibaba
BABA
$280B
$3.06M 3.26%
17,750
-7,250
-29% -$1.3M
CBM
11
DELISTED
Cambrex Corporation
CBM
$2.42M 2.58%
50,519
– –
JNP
12
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$2.07M 2.2%
426,903
– –
CPIX icon
13
Cumberland Pharmaceuticals
CPIX
$103M
$1.94M 2.07%
263,881
– –
LGND icon
14
Ligand Pharmaceuticals
LGND
$5.87B
$1.83M 1.95%
21,482
– –
MU icon
15
Micron Technology
MU
$874B
$1.69M 1.79%
41,000
– –
ALIM
16
DELISTED
Alimera Sciences
ALIM
$1.28M 1.37%
64,400
– –
NVLN
17
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$986K 1.05%
315,979
-1
-0% -$5
BBBY
18
Bed Bath & Beyond
BBBY
$481M
$639K 0.68%
+13,310
New +$481K
ADVM
19
DELISTED
Adverum Biotechnologies
ADVM
$625K 0.67%
17,865
– –
ARLZ
20
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$411K 0.44%
289,664
– –
SNOA icon
21
Sonoma Pharmaceuticals
SNOA
$5.31M
$223K 0.24%
228
-333
-59% -$285K
TLGT
22
DELISTED
Teligent, Inc
TLGT
$50K 0.05%
1,382
– –
ANIP icon
23
ANI Pharmaceuticals
ANIP
$1.86B
– –
-29,722
Closed -$1.56M
CMG icon
24
Chipotle Mexican Grill
CMG
$44B
– –
-450,000
Closed -$2.77M
IBB icon
25
iShares Biotechnology ETF
IBB
$9.55B
– –
-17,484
Closed -$1.94M
1
2

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return
VG
Visualize Group New York $243M AUM 6.21% 1-Year Est. Return
CP
Creekside Partners Petaluma, California $243M AUM 20.23% 1-Year Est. Return

JW Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, JW Asset Management held 30 positions worth $94M, down 31% from $137M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

JW Asset Management withdrew a net $40.4M in Q4 2017, closing 8 positions and reducing 6 holdings. Its most notable exit was State Street SPDR S&P Biotech ETF, an estimated $6.06M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, up from 49% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, JW Asset Management opened a new position in Bed Bath & Beyond worth $639K.

  • JW Asset Management's largest Q4 2017 buy was Bed Bath & Beyond: 13,310 shares worth $639K.
  • JW Asset Management added most to PetIQ, Inc. Class A Common Stock in Q4 2017, an estimated $3.43M increase.
  • JW Asset Management's biggest Q4 2017 reduction was Meta Platforms (Facebook), cutting an estimated $3.09M.
  • JW Asset Management fully exited State Street SPDR S&P Biotech ETF in Q4 2017, selling an estimated $6.06M.
  • JW Asset Management's ten largest holdings make up 85% of its $94M portfolio in Q4 2017.
  • JW Asset Management opened 1 new position and closed 8 in Q4 2017.
  • JW Asset Management's portfolio value fell 31% quarter-over-quarter to $94M.

Based on JW Asset Management's 13F filing for Q4 2017, filed 12 Feb 2018.